Company · CIK 0001840229 · SIC 2836 — Biological Products, (No Diagnostic Substances) · Nasdaq
MiNK Therapeutics, Inc. · INKT
Insider activity reported against this company. All insider holders · On EDGAR ↗
Reported at this company — common stock
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Sep 1, 2026 AForm 4 → | Sep 2, 11:10 am EDT | Ulf WiinbergDirector | 1,279 | $10.95 | $14,005 | 23,929 | — | |
| Sep 1, 2026 AForm 4 → | Sep 2, 10:21 am EDT | John Bradley HolcombDirector | 1,233 | $10.95 | $13,501 | 4,691 | — | |
| Sep 1, 2026 AForm 4 → | Sep 2, 10:20 am EDT | Peter BehnerDirector | 1,485 | $10.95 | $16,261 | 24,404 | — | |
| Sep 1, 2026 AForm 4 → | Sep 2, 10:19 am EDT | Barbara RyanDirector | 1,622 | $10.95 | $17,761 | 23,591 | — | |
| Sep 1, 2026 AForm 4 → | Sep 2, 10:16 am EDT | Brian CorveseDirector | 1,633 | $10.95 | $17,881 | 54,770 | — |
Reported at this company — derivatives (options, RSUs, warrants)
No reported derivative activity in this period.